Age years | 11.9 (11.3–12.5) |
Age <12 years | 47 (45) |
Sex male | 60 (58) |
Overweight¶ | 20 (19) |
History of asthma | |
Duration of asthma years | 9.1 (8.3–9.9) |
Exercise induced asthma | 89 (86) |
≥1 ED attendance ever | 70 (68) |
Ever hospitalised | 77 (74) |
Ever hospitalised in ICU | 17 (16.5) |
Allergy and allergic comorbidities | |
Allergic rhinitis | 88 (84.5) |
Atopic dermatitis | 35 (34) |
Food allergy | 36 (35) |
Total IgE levels kU·L−1 | 1125 (934–1315) |
Sensitisation to aeroallergens | 101 (97) |
>2 sensitisations | 69 (66) |
Asthma-related events in the previous year | |
Exacerbation rate | 4.4 (3.7–5.2) |
>2 oral steroid courses | 68 (65.5) |
ED visit | 70 (67) |
Hospitalisation | 46 (44) |
>1 hospitalisation | 20 (19) |
Hospitalisation in ICU | 8 (7.7) |
Asthma medication at baseline | |
ICS | 104 (100) |
Dose of ICS fluticasone equivalent μg·day−1 | 703 (642–764) |
Association with LABA | 98 (94) |
>2 long-term controller medication | 93 (89.5) |
Daily SABA | 48 (46) |
Maintenance oral corticosteroids | 6 (5.5) |
Lung function tests | |
FEV1 % pred | 88 (83.8–92.2) |
FEV1/FVC % | 75.8 (72.5–79.1) |
FEF25–75% % pred | 65.1 (58.8–71.4) |
Asthma control | |
Poor | 85 (82) |
Partial | 19 (18) |
Good | 0 (0) |